This inventor holds 1 USPTO granted patent. Top assignee: Km Biologics Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Kanae Ishikawa: Innovator in Vaccine Development
Introduction
Kanae Ishikawa is a prominent inventor based in Kikuchi, Japan. She has made significant contributions to the field of vaccine development, particularly with her innovative work on combined vaccine formulations. Her dedication to improving public health through scientific advancements is commendable.
Latest Patents
Kanae Ishikawa holds a patent for a liquid six combined vaccine composition. This formulation includes DPT-IPV-Hib-HBs, where a hepatitis B surface (HBs) antigen is stably adsorbed to an aluminum adjuvant. The patent outlines a method for producing a stable liquid formulation that effectively combines vaccines against diphtheria, pertussis, tetanus, polio, type b (Hib), and hepatitis B (HepB). The detailed process involves several steps, including mixing various antigens with adjuvants and adjusting the pH to ensure stability.
Career Highlights
Kanae Ishikawa is associated with Km Biologics Co., Ltd., where she continues to work on innovative vaccine solutions. Her expertise in immunology and vaccine formulation has positioned her as a key player in the industry. With a focus on creating effective and safe vaccines, she has contributed to advancements that benefit public health.
Collaborations
Kanae collaborates with notable colleagues, including Haruna Iwata and Kazuhiro Daimon. These partnerships enhance her research and development efforts, allowing for a multidisciplinary approach to vaccine innovation.
Conclusion
Kanae Ishikawa's work in vaccine development exemplifies her commitment to advancing healthcare through innovation. Her contributions, particularly in creating a stable combined vaccine formulation, highlight her role as a leading inventor in the field.